Greywolf Capital Management Trims Exposure to Rubicon Minerals Corp. (USA) (RBY)

Greywolf Capital Management, led by Jonathan Savitz has disclosed, in an amended filing with the SEC, halving its position in Rubicon Minerals Corp. (USA) (NYSEMKT:RBY). The fund currently holds around 7.9 million shares of the company, versus 14.4 million held at the end of September as reported in the latest 13F filing. The stake is passive by nature and amasses 2.7% of the company’s common stock.

Rubicon Minerals Corp

Rubicon Minerals Corp. (USA) (NYSEMKT:RBY), the basic materials exploration company, which operates in the U.S and Canada. One of its largest explorative grounds is the 65,000 acreage Red Lake gold camp in Ontario. However, its main site is Phoenix Gold Property, a mine which Rubicon Minerals Corp. (USA) (NYSEMKT:RBY) fully owns and manages.

Hedge Funds which hold top three positions in Rubicon Minerals Corp. (USA) (NYSEMKT:RBY) include Sun Valley Gold, managed by Peter Franklin Palmedo holding 7.26 million shares valued at $9.23 million. D. E. Shaw’s D E Shaw owns 1.13 million shares, worth $1.45 million. Next largest holder is Jim SimonsRenaissance Technologies holding 340,600 shares valued at $0.43 million.

Greywolf Capital Management’s portfolio of investments includes Industrial Goods, Financials and Healthcare, besides minor holding in Basic Materials, Services and Others. The fund uses “opportunistic credit-based and fundamental analysis-driven investment strategies”and employs a value investing philosophy.

Greywolf Capital Management announced recently that it increased its exposure in Enpro Industries, Inc. (NYSE:NPO) from around 850,000 shares to 1.3 million shares. During the third quarter, the fund has also added American International Group Inc (NYSE:AIG) to its equity portfolio and currently holds 859,100 shares valued at $41.7 million.

Disclosure: none

Recommended Reading:

Clinton Group Sells Some More ValueVision Media Inc (VVTV) Shares

Abrams Capital Management Trims the Stake in Engility Holdings Inc (EGL)

Glenview Capital Further Increases Position in Tenet Healthcare Corp (THC)

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!